KY HB532

Establishes a regulatory framework for "medicinal hemp products" defined as nonintoxicating dietary supplements derived from hemp containing only naturally occurring cannabinoids with delta-9 THC concentration not exceeding 0.3%

Requires each batch of medicinal hemp product to undergo independent laboratory testing for cannabinoid profile, THC compliance, pesticides, microbial contaminants, residual solvents, and mycotoxins, with results made publicly accessible via QR code

Mandates specific labeling requirements including batch number, cannabinoid content per serving, ingredient list, expiration date, remediation disclosure, and federal disclaimers stating the product is not FDA-evaluated and not intended to treat disease

Grants the Kentucky Department of Agriculture exclusive authority over medicinal hemp product regulation, with licensing priority given to existing Kentucky hemp growers, family farms, and small agricultural operations over large-scale or vertically integrated operators

Declares an emergency for immediate effect upon passage to enable Kentucky hemp producers to participate in any federal purchasing or reimbursement pathways that may become available for hemp-derived products